| Product Code: ETC7658226 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of PD-1 and PD-L1 inhibitors to Israel in 2024 were primarily sourced from Switzerland, UK, Belgium, USA, and Germany. Despite the top exporters, the market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained very low in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was -2.14%, with a slight decline in the growth rate from 2023 to 2024 at -0.41%. These figures suggest a relatively stable market for PD-1 and PD-L1 inhibitors in Israel with a diverse range of importing countries contributing to the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel PD-1 and PD-L1 Inhibitors Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, 2022 & 2032F |
3.3 Israel PD-1 and PD-L1 Inhibitors Market - Industry Life Cycle |
3.4 Israel PD-1 and PD-L1 Inhibitors Market - Porter's Five Forces |
3.5 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Inhibitors, 2022 & 2032F |
3.6 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Israel PD-1 and PD-L1 Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing awareness and adoption of immunotherapy for cancer treatment |
4.2.3 Favorable government initiatives and policies supporting the use of PD-1 and PD-L1 inhibitors |
4.3 Market Restraints |
4.3.1 High cost associated with PD-1 and PD-L1 inhibitors |
4.3.2 Stringent regulatory requirements for drug approval in Israel |
4.3.3 Limited accessibility and availability of advanced cancer treatments in certain regions |
5 Israel PD-1 and PD-L1 Inhibitors Market Trends |
6 Israel PD-1 and PD-L1 Inhibitors Market, By Types |
6.1 Israel PD-1 and PD-L1 Inhibitors Market, By Inhibitors |
6.1.1 Overview and Analysis |
6.1.2 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Inhibitors, 2022 - 2032F |
6.1.3 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By PD-1 Inhibitors, 2022 - 2032F |
6.1.4 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By PD-L1 Inhibitors, 2022 - 2032F |
6.2 Israel PD-1 and PD-L1 Inhibitors Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Hodgkin Lymphoma, 2022 - 2032F |
6.2.3 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Kidney Cancer, 2022 - 2032F |
6.2.4 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Melanoma, 2022 - 2032F |
6.2.5 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Non-small Cell Lung Cancer, 2022 - 2032F |
6.2.6 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Other Applications, 2022 - 2032F |
6.3 Israel PD-1 and PD-L1 Inhibitors Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.3.3 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.3.4 Israel PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
7 Israel PD-1 and PD-L1 Inhibitors Market Import-Export Trade Statistics |
7.1 Israel PD-1 and PD-L1 Inhibitors Market Export to Major Countries |
7.2 Israel PD-1 and PD-L1 Inhibitors Market Imports from Major Countries |
8 Israel PD-1 and PD-L1 Inhibitors Market Key Performance Indicators |
8.1 Patient survival rates post-treatment with PD-1 and PD-L1 inhibitors |
8.2 Number of clinical trials and research studies focused on these inhibitors in Israel |
8.3 Adoption rate of immunotherapy compared to traditional cancer treatments in the country |
9 Israel PD-1 and PD-L1 Inhibitors Market - Opportunity Assessment |
9.1 Israel PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Inhibitors, 2022 & 2032F |
9.2 Israel PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Israel PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Israel PD-1 and PD-L1 Inhibitors Market - Competitive Landscape |
10.1 Israel PD-1 and PD-L1 Inhibitors Market Revenue Share, By Companies, 2025 |
10.2 Israel PD-1 and PD-L1 Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here